STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 53.e23-53.e29

  Gomes, Inês M ^a   Arinto, Patrícia ^b   Lopes, Carlos ^b,c   Santos, Cecília R ^a   Maia, Cláudio J ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Centro Hospitalar Universitario do Porto   (Portugal)

Author keywords

Biomarker; BPH; Gleason score; PIN; Prostate cancer; STEAP1

Indexed keywords

MEMBRANE PROTEIN; STEAP1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURGERY; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; GENE OVEREXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; VERY ELDERLY;

BIOMARKER; BPH; GLEASON SCORE; PIN; PROSTATE CANCER; STEAP1;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; OXIDOREDUCTASES; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; ROC CURVE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84890801992     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.08.028     Document Type: Article

References (30)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Berney D., Cheng L. Prostate cancer: towards the standardization and synthesis of morphology, genetics, and prognosis. Histopathology 2012, 60:1-3.
3. Joshua A., Evans A., Van der Kwast T., et al. Prostatic preneoplasia and beyond. Biochim Biophys Acta 2008, 1785:156-181.
4. Mimeault M., Batra S.K. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis 2006, 27:1-22.
5. Kelloff G.J., Sigman C.C. Cancer biomarkers: selecting the right drug for the right patient. Nat Rev Drug Discov 2012, 11:201-214.
6. Gomes I.M., Santos C.R., Socorro S., Maia C.J. Six transmembrane epithelial antigen of the prostate 1 is down-regulated by sex hormones in prostate cells. Prostate 2012, 73:605-613.
7. Hubert R.S., Vivanco I., Chen E., et al. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci U S A 1999, 96:14523-14528.
8. Maia C.J.B., Socorro S., Schmitt F., Santos C.R. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland. Endocrine 2008, 34:108-116.
9. Yang D., Holt G.E., Velders M.P., Kwon E.D., Kast W.M. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res 2001, 61:5857-5860.
10. Challita-Eid P.M., Morrison K., Etessami S., et al. Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo. Cancer Res 2007, 67:5798-5805.
11. Lalani E.-N., Laniado M.E., Abel P.D. Molecular and cellular biology of prostate cancer. Cancer Metastasis Rev 1997, 16:29-66.
12. Pan Y., Li Y., Guo L., Zhao Y., Zhao X. Influence of expression of six transmembrane epithelial antigen of the prostate-1 on intracellular reactive oxygen species level and cell growth: an in vitro experiment. Zhonghua Yi Xue Za Zhi 2008, 88:641-644.
13. Smith P., Rhodes N.P., Shortland A.P., et al. Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett 1998, 423:19-24.
14. Grunewald T., Ranft A., Esposito I., et al. High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients. Ann Oncol 2012, 23:2185-2190.
15. Gomes I.M., Maia C.J., Santos C.R. STEAP proteins: from structure to applications in cancer therapy. Mol Cancer Res 2012, 10:573-587.
16. Valenti M.T., Dalle Carbonare L., Donatelli L., et al. STEAP mRNA detection in serum of patients with solid tumours. Cancer Lett 2009, 273:122-126.
17. Edge S.B., Compton C.C. The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol 2010, 17:1471-1474.
18. Monteiro L.S., Ricardo S., Delgado M.L., Garcez F., do Amaral B., Lopes C. Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas. Oral Dis 2013, Doi: 10.1111/odi.12087.
19. Pértega-Gomes N., Vizcaíno J.R., Gouveia C., et al. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer. Prostate 2012, 73:763-769.
20. Prensner J.R., Rubin M.A., Wei J.T., Chinnaiyan A.M. Beyond PSA: the next generation of prostate cancer biomarkers. Sci Transl Med 2012, 4:127rv3.
21. Lilja H., Ulmert D., Vickers A.J. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer 2008, 8:268-278.
22. Brawer M.K. Prostate-specific antigen: current status CA Cancer J Clin 1999, 49:264-281.
23. Balk S.P., Ko Y.-J., Bubley G.J. Biology of prostate-specific antigen. J Clin Oncol 2003, 21:383-391.
24. Wolf A., Wender R.C., Etzioni R.B., et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010, 60:70-98.
25. Lucia M.S., Darke A.K., Goodman P.J., et al. Pathologic characteristics of cancers detected in the Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention. Cancer Prev Res 2008, 1:167-173.
26. Grunewald T.G., Diebold I., Esposito I., et al. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors. Mol Cancer Res 2012, 10:52-65.
27. Bonkhoff H., Stein U., Remberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994, 24:114-118.
28. Bonkhoff H., Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 1996, 28:98-106.
29. Vaghjiani R.J., Talma S., Murphy C.L. Six-transmembrane epithelial antigen of the prostate (STEAP1 and STEAP2)-Differentially expressed by murine and human mesenchymal stem cells. Tissue Eng Part A 2009, 15:2073-2083.
30. Moreaux J., Kassambara A., Hose D., Klein B. STEAP1 is overexpressed in cancers: a promising therapeutic target. Biochem Biophys Res Commun 2012.